Trials / Sponsors / Matrix Biomed, Inc.
Matrix Biomed, Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia Ataxia Telangiectasia Louis-Bar, Ataxia Telangiectasia in Children, Ataxia Telangiectasia | Phase 2 | 2021-07-01 |
| Unknown | MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM) Glioblastoma, Glioblastoma Multiforme | Phase 2 | 2021-06-01 |
| Unknown | MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer Prostate Cancer Recurrent, Biochemical Recurrent Prostate Cancer | Phase 2 | 2021-05-30 |
| Recruiting | Treatment of Radiation and Cisplatin Induced Toxicities with Tempol Mucositis, Nephrotoxicity, Ototoxicity | Phase 2 | 2019-05-13 |
| Available | A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer Prostate Cancer | — | — |
| Available | Treatment of Metastatic Cancer in Terminally Diagnosed Patients Metastatic Cancer | — | — |